Life sciences M&A value of portfolio optimization worldwide by therapeutic area 2020

Published by
Matej Mikulic,
Aug 3, 2020
Oncology was the therapeutic area with the largest potential in M&A value of protfolio optimization, as of early 2020. The potential deal multiplier stood at six, with a potential asset value of 84 billion U.S. dollars. This statistic illustrates the life sciences M&A value of portfolio optimization worldwide as of 2020, by five selected therapeutic areas.

Life sciences M&A value of portfolio optimization worldwide as of 2020, by select therapeutic area

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

January 2020

Region

Worldwide

Survey time period

as of January 2020

Number of respondents

base: 30 leading life sciences companies

Supplementary notes

Modeling assumes assets are divestiture candidates if owners’ revenues total 3% or less of total therapy area revenues.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

1

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology in SpainGlobal pharmaceutical industryBiotech drugsBiotechnology industry in Germany Biotechnology in Europe
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu